These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30930425)

  • 1. Ginsenoside Rg3 Combined with Oxaliplatin Inhibits the Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells via Downregulating PCNA and Cyclin D1.
    Shan K; Wang Y; Hua H; Qin S; Yang A; Shao J
    Biol Pharm Bull; 2019 Jun; 42(6):900-905. PubMed ID: 30930425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
    Lu M; Fei Z; Zhang G
    Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
    Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
    Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway.
    Jiang JW; Chen XM; Chen XH; Zheng SS
    World J Gastroenterol; 2011 Aug; 17(31):3605-13. PubMed ID: 21987607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic.
    Pu Z; Ge F; Wang Y; Jiang Z; Zhu S; Qin S; Dai Q; Liu H; Hua H
    Bioengineered; 2021 Dec; 12(1):2398-2409. PubMed ID: 34130594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma.
    Wang B; Xu Q; Zhou C; Lin Y
    Acta Biochim Pol; 2021 Nov; 68(4):711-715. PubMed ID: 34730903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma.
    Guo B; Li L; Guo J; Liu A; Wu J; Wang H; Shi J; Pang D; Cao Q
    Oncotarget; 2017 Jul; 8(27):44465-44476. PubMed ID: 28591705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
    Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
    Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
    Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
    Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
    Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticarcinogenic effect of 20(R)-ginsenoside Rg3 on induced hepatocellular carcinoma in rats].
    Li X; Guan YS; Zhou XP; Sun L; Liu Y; He Q; Fu L; Mao YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):217-20. PubMed ID: 15807271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.
    Lee YJ; Lee S; Ho JN; Byun SS; Hong SK; Lee SE; Lee E
    Oncol Rep; 2014 Nov; 32(5):1803-8. PubMed ID: 25175462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
    Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
    Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
    Hong M; Almutairi MM; Li S; Li J
    Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1].
    Jian J; Hu ZF; Huang Y
    Ai Zheng; 2009 May; 28(5):461-5. PubMed ID: 19624871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
    Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
    Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α.
    Ge X; Zhen F; Yang B; Yang X; Cai J; Zhang C; Zhang S; Cao Y; Ma J; Cheng H; Sun X
    J Int Med Res; 2014 Jun; 42(3):628-40. PubMed ID: 24691458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.